Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday, 7 December 2015

The CDK9 inhibitor dinaciclib exerts potent apoptotic and antitumor effects in preclinical models of MLL-rearranged acute myeloid leukemia

Jake Shortt et al. published in Cancer Research.

Read article here.

No comments:

Post a Comment